Terms: = Colorectal cancer AND AFP, AFPD, FETA, HPAFP AND Diagnosis
56 results:
1. [colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases].
Wang Q; Zhang Y; Tan C; Ni SJ; Huang D; Chang B; Sheng WQ; Wang L
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):370-376. PubMed ID: 38556821
[No Abstract] [Full Text] [Related]
2. Case report: hepatic arterial infusion chemotherapy combined with sintilimab and lenvatinib for conversion therapy of colorectal cancer liver metastases.
Peng K; Li Y; Su H; Lan C; Huang Z; Wei Y; Liao X; Peng M; Peng T; Zhu G
Front Immunol; 2023; 14():1325445. PubMed ID: 38173715
[TBL] [Abstract] [Full Text] [Related]
3. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in colorectal cancer.
Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
[TBL] [Abstract] [Full Text] [Related]
4. Integrated microbiome and metabolome analysis reveals the interaction between intestinal flora and serum metabolites as potential biomarkers in hepatocellular carcinoma patients.
Li X; Yi Y; Wu T; Chen N; Gu X; Xiang L; Jiang Z; Li J; Jin H
Front Cell Infect Microbiol; 2023; 13():1170748. PubMed ID: 37260707
[TBL] [Abstract] [Full Text] [Related]
5. Hepatoid adenocarcinoma-Clinicopathological features and molecular characteristics.
Li M; Mei YX; Wen JH; Jiao YR; Pan QR; Kong XX; Li J
Cancer Lett; 2023 Apr; 559():216104. PubMed ID: 36863507
[TBL] [Abstract] [Full Text] [Related]
6. Establishment of matrix metalloproteinase 3 time-resolved immunoassay and some potential clinical applications.
Fu Y; Wang X; Chen X; Hong J; Qin Y; Zhou Z; Zhou X; Wang Y; Zhou J; Fang H; Liu P; Huang B
Anal Biochem; 2023 Apr; 666():115072. PubMed ID: 36738873
[TBL] [Abstract] [Full Text] [Related]
7. Clinical Value of PET.CT Based on Big Data in colorectal and Peritoneal Metastatic cancer.
Xiang L; Yang C; Liu W; Li D; Jiang Z; Zhou H
Contrast Media Mol Imaging; 2022; 2022():6120337. PubMed ID: 36262991
[TBL] [Abstract] [Full Text] [Related]
8. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
[TBL] [Abstract] [Full Text] [Related]
9. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract] [Full Text] [Related]
10. The Expression and Clinical Significance of PCNAP1 in Hepatocellular Carcinoma Patients.
Chen Y; Zhang J; Liu J; Wang J; Shi C; Lu L; Cheng X; Niu G; Zhang S
J Immunol Res; 2022; 2022():1817694. PubMed ID: 35224110
[TBL] [Abstract] [Full Text] [Related]
11. Metabolic Profiling Identified a Novel Biomarker Panel for Metabolic Syndrome-Positive Hepatocellular cancer.
Cao LL; Han Y; Wang Y; Pei L; Yue Z; Qin L; Liu B; Cui J; Jia M; Wang H
Front Endocrinol (Lausanne); 2021; 12():816748. PubMed ID: 35154012
[TBL] [Abstract] [Full Text] [Related]
12. Assessment of structural protein expression by FTIR and biochemical assays as biomarkers of metabolites response in gastric and colon cancer.
Guleken Z; Bulut H; Gültekin Gİ; Arıkan S; Yaylım İ; Hakan MT; Sönmez D; Tarhan N; Depciuch J
Talanta; 2021 Aug; 231():122353. PubMed ID: 33965021
[TBL] [Abstract] [Full Text] [Related]
13. Performance evaluation of CA242 by flow fluorescence assay.
Hou Y; Chen Y; Sun J; Geng J; Jin H; Zhang Z
Medicine (Baltimore); 2021 Apr; 100(15):e25301. PubMed ID: 33847629
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Significance of Annexin A4 as a Biomarker in the Early diagnosis of Hepatocellular Carcinoma.
Saad ZM; Fouad Y; Ali LH; Hassanin TM
Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
[TBL] [Abstract] [Full Text] [Related]
15. Synergistic effects of extracellular vesicle phenotyping and afp in hepatobiliary cancer differentiation.
Urban SK; Sänger H; Krawczyk M; Julich-Haertel H; Willms A; Ligocka J; Azkargorta M; Mocan T; Kahlert C; Kruk B; Jankowski K; Patkowski W; Krawczyk M; Zieniewicz K; Hołówko W; Krupa Ł; Rzucidło M; Gutkowski K; Wystrychowski W; Król R; Raszeja-Wyszomirska J; Słomka A; Schwab R; Wöhler A; Gonzalez-Carmona MA; Gehlert S; Sparchez Z; Banales JM; Strassburg CP; Lammert F; Milkiewicz P; Kornek M
Liver Int; 2020 Dec; 40(12):3103-3116. PubMed ID: 32614460
[TBL] [Abstract] [Full Text] [Related]
16. [Variation in morphology or two entities?].
Gerber TS; Paschold M; Lang H; Roth W; Straub BK
Pathologe; 2020 Feb; 41(1):70-72. PubMed ID: 31938820
[TBL] [Abstract] [Full Text] [Related]
17. Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
Cao G; Xie Y; Jiang X; Tian X; Wang D; Sun Y
Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):44-51. PubMed ID: 31472046
[TBL] [Abstract] [Full Text] [Related]
18. One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report.
Tartaglia N; Di Lascia A; Cianci P; Fersini A; Sanguedolce F; Iadarola R; Capuzzolo S; Neri V; Ambrosi A
Ann Ital Chir; 2017 Nov; 6():. PubMed ID: 29176078
[TBL] [Abstract] [Full Text] [Related]
19. [Standardized diagnosis and treatment of colorectal liver metastasis].
Yao H; Zhang Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):753-757. PubMed ID: 28722087
[TBL] [Abstract] [Full Text] [Related]
20. Diagnostic Performance of a Novel Multiplex Immunoassay in colorectal cancer.
Dressen K; Hermann N; Manekeller S; Walgenbach-Bruenagel G; Schildberg FA; Hettwer K; Uhlig S; Kalff JC; Hartmann G; Holdenrieder S
Anticancer Res; 2017 May; 37(5):2477-2486. PubMed ID: 28476816
[TBL] [Abstract] [Full Text] [Related]
[Next]
